http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1575945-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14 |
| filingDate | 2003-12-15^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f5646399f638046842bc3f26c5f37f8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bee76c24cb25cd80697be1c70fe0c085 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5780a5ea07b3bae1fc0a9f244ca672ff |
| publicationDate | 2005-09-21^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1575945-A1 |
| titleOfInvention | Oxazolidinone derivatives as antibacterial |
| abstract | A compound of the formula (I), or a pharmaceutically-acceptable salt, or in-vivo hydrolysable ester thereof : formula (I), wherein C is selected from D and E, formula (D), formula (E), R2a, R6a, and R3a are independently selected from for example H, CF3, Me and Et; R2b and R6b are independently selected from for example H, F, CF3, Me and Et; R1b is -X-Z wherein X is O or S and Z is a C-linked 5- or 6-membered heteroaryl ring; R4 is for example an optionally substituted 5- or 6-membered heterocyclic ring system. Methods for making compounds of the formula (I), compositions containing them and their use as antibacterial agents are also described. |
| priorityDate | 2002-12-19^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 853 of 853.